Life Sciences Alternative Funding

Total investments

4

Average round size

11M

Portfolio companies

4

Exits

3

Stages of investment
Debt
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedical

Summary

The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the White Plains.

The usual cause for the fund is to invest in rounds with 1 partaker. Despite the Life Sciences Alternative Funding, startups are often financed by Wellcome Trust, InterWest Partners, Three Arch Partners. In the next rounds fund is usually obtained by Saints Capital, SWK Funding, InterWest Partners.

Among the various public portfolio startups of the fund, we may underline Imprimis Pharmaceuticals, Integrated Diagnostics, VisionCare Ophthalmic Technologies The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Health Diagnostics, Medical Device. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2018. This Life Sciences Alternative Funding works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015.

Show more

Investments analytics

Analytics

Total investments
4
Lead investments
0
Exits
3
Investments by industry
  • Health Care (4)
  • Medical (3)
  • Biotechnology (3)
  • Medical Device (2)
  • Health Diagnostics (1)
Investments by region
  • United States (4)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
19
Avg. valuation at time of investment
40M
Avg. company exit year
10
Avg. multiplicator
0.62

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.